These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Dialysis encephalopathy.
    Author: Alfrey AC.
    Journal: Clin Nephrol; 1985; 24 Suppl 1():S15-9. PubMed ID: 3915955.
    Abstract:
    Dialysis encephalopathy is a progressive neurological disease which usually causes death in six to eight months. Although primarily occurring in hemodialyzed uremic patients, it is being seen with increasing frequency in non-dialyzed uremic patients and patients on peritoneal dialysis. Based on strong biochemical and epidemiological data, aluminum has been implicated in the pathogenesis of this disease. Although the source of the aluminum loading was initially felt to be from aluminum-contaminated dialysate, it has more recently become apparent that aluminum loading can occur from the orally administered, aluminum-containing, phosphate-binding gels. In view of the known toxicity of aluminum, the minimum amount of aluminum-containing, phosphate-binding gels should be administered to control serum phosphorus levels, and alternate methods of phosphate control should be sought.
    [Abstract] [Full Text] [Related] [New Search]